Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Parkinson's disease
Biotech
Servier severing forces OPM to make 'drastic choices' to adapt
The loss of a shot at a milestone prompted OPM to lay off staff and halve the salaries of two top executives.
Nick Paul Taylor
Apr 4, 2025 9:05am
Cerevance fails phase 2 trial in early, untreated Parkinson's
Apr 1, 2025 10:19am
Newronika nets CE mark for adaptive DBS in Parkinson's disease
Mar 26, 2025 10:36am
Hologen AI commits $430M to MeiraGTx Parkinson's gene therapy
Mar 13, 2025 10:51am
Celon's PDE10A inhibitor reduces movements in Parkinson's trial
Mar 5, 2025 6:45am
FDA approves Medtronic’s adaptive DBS implant for Parkinson’s
Feb 24, 2025 10:48am
